Strain Information | |
---|---|
Image | |
BRC No. | RBRC06138 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129P2-Serpina12<tm1> |
Former Common name | Vaspin KO, B6-Serpina12 KO, Vaspin-/- |
H-2 Haplotype | |
ES Cell line | BK4 [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | Developed by Jun Wada, Department of Medicine and Clinical Science, Okayama University and Yoichiro Iwakura, Institute of Medical Sciences, University of Tokyo in 2008. 129P2 derived ES cells were used. The mutant mice were backcrossed to C57BL/6 over 10 times. |
Strain description | Vaspin (Serpina12) gene knockout mice. Exon 2 was deleted. Homozygous mutant mice fed with a high-fat-high sucrose diet exhibit increase in body weight, fad pad, liver weight and deterioration of insulin sensitivity. |
Colony maintenance | Homozygote x Homozygote [or Crossing to C57BL/6JJcl] |
References | Vaspin is an adipokine ameliorating ER stress in obesity as a ligand for cell-surface GRP78/MTJ-1 complex. Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Horiguchi C S, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H Diabetes, 61, 2823-2832, (2012). 22837305Visceral adipose tissue-derived serine proteinase inhibitor inhibits apoptosis of endothelial cells as a ligand for the cell-surface GRP78/voltage-dependent anion channel complex. Nakatsuka A, Wada J, Iseda I, Teshigawara S, Higashio K, Murakami K, Kanzaki M, Inoue K, Terami T, Katayama A, Hida K, Eguchi J, Ogawa D, Matsuki Y, Hiramatsu R, Yagita H, Kakuta S, Iwakura Y, Makino H Circ Res., 112, 771-780 (2013). 23307819 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Serpina12 MGI:1915304 | serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12 | 12 | Serpina12<tm1Jwada> | targeted mutation 1, Jun Wada | |||
loxP | phage P1 loxP | 12 | loxP | ||||
loxP | phage P1 loxP | 12 | loxP | ||||
neo | neomycin resistance gene (E. coli) | 12 | mouse phosphoglycerate kinase promoter (PGK promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | more 6 phenotypes |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | mouse phosphoglycerate kinase promoter (PGK promoter), E. coli neo, phage P1 loxP, Mouse Serpina12 genomic DNA |
Research application | Cre/loxP system Diabetes and Obesity Research Metabolism Research Mouse Models for Human Disease covid19_progression |
Specific Term and Conditions | No specific terms and conditions. (The DEPOSITOR waives its own rights under any patents, intellectual property, or other proprietary rights with respect to the results to be obtained by use of the BIOLOGICAL RESOURCE.) |
Depositor | Jun Wada (Okayama University) |
Strain Status | ![]() |
Strain Availability | Recovered litters from cryopreserved sperm (2 to 4 months) Cryopreserved sperm (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |